• March 2022: Lu-177 vipivotide tetraxetan & Ga-68 gozetotide receive FDA approval for prostate cancer
  • May 2020: Cerianna (F-18 fluoroestradiol) receives FDA approval for ER+ breast cancer imaging
  • Access the latest issues of the JNM and the JNMT
  • Learn about the Facilitating Innovative Nuclear Diagnostics (FIND) Act
  • March 2021:SNMMI Statement on COVID-19 and Ventilation/Perfusion (V/Q) Lung Studies
  • March 2021:SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT

Ralph Robinson Lecturers

2015 Reginald Dusing, MD
2012 Bennett Greenspan, MD
2007 Jerold Wallis, MD
2006 Michael M. Graham, PhD, MD
2005 Robert F. Carretta, MD
2004 Henry D. Royal, MD
2002 Dr. Glenn Dalrymple
2001 Barry A. Siegel, MD
2000 R. Edward Coleman, MD
1999 Wynn A. Volkert, PhD
1998 Peter T. Kirchner, MD
1997 David F. Preston, MD
1996 Michael J. Welch, PhD
1995 James W. Fletcher, MD
1994 Richard A. Holmes, MD

Lifetime Achievement Award

2007 Tom R. Miller, MD, PhD

2024 Fall Annual Meeting

Thanks to everyone for another great annual meeting! We appreciate everyone who attended in person and virtually. We would also like to extend our heartfelt appreciation to our outstanding group of speakers for their time and expertise.

Attendance verification forms for meeting participants have been submitted to the SNMMI for CE processing. Click here for a copy of the CE approval letter from the SNMMI if needed for your records. Please note: the SNMMI Learning Center website will be unavailable from Oct. 18 to at least Nov. 1, so processing of CE certificates will be delayed.

Make plans to join us back in Kansas City for the 2025 Annual Meeting: Sept. 26-28, 2025 at the same Embassy Suites Kansas City Int'l Airport Hotel!